Heparin Market Size, Share & Trends Analysis Report By Type, By Route of Administration, By Application, By End-use (Outpatient, Inpatient), By Source, By Region, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Heparin Market: Methodology and Scope
                   1.1. Market Segmentation & Scope
                   1.2. Segment Definitions
                       1.2.1. Type
                       1.2.2. Route of administration
                       1.2.3. Application
                       1.2.4. End-use
                       1.2.5. Source
                       1.2.6. Regional scope
                       1.2.7. Estimates and forecasts timeline
                   1.3. Research Methodology
                   1.4. Information Procurement
                       1.4.1. Purchased database
                       1.4.2. GVR’s internal database
                       1.4.3. Secondary sources
                       1.4.4. Primary research
                       1.4.5. Details of primary research
                           1.4.5.1. Data for primary interviews in North America
                           1.4.5.2. Data for primary interviews in Europe
                           1.4.5.3. Data for primary interviews in Asia Pacific
                           1.4.5.4. Data for primary interviews in Latin America
                           1.4.5.5. Data for Primary interviews in MEA
                   1.5. Information or Data Analysis
                       1.5.1. Data analysis models
                   1.6. Market Formulation & Validation
                   1.7. Model Details
                       1.7.1. Commodity flow analysis (Model 1)
                       1.7.2. Approach 1: Commodity flow approach
                       1.7.3. Volume price analysis (Model 2)
                       1.7.4. Approach 2: Volume price analysis
                   1.8. List of Secondary Sources
                   1.9. List of Primary Sources
                   1.10. Objectives
Chapter 2. Heparin Market: Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Outlook
                       2.2.1. Type
                       2.2.2. Route of Administration
                       2.2.3. Application
                       2.2.4. End-use
                       2.2.5. Source
                       2.2.6. Regional outlook
                   2.3. Competitive Insights
Chapter 3. Heparin Market: Variables, Trends & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent market outlook
                       3.1.2. Related/ancillary market outlook
                   3.2. Market Dynamics
                       3.2.1. Market driver analysis
                           3.2.1.1. Increasing prevalence of chronic diseases
                           3.2.1.2. Growing demand for whole blood and blood components transfusion
                           3.2.1.3. Increasing geriatric population
                           3.2.1.4. High usage of plasma in the pharmaceutical industry
                       3.2.2. Market restraint analysis
                           3.2.2.1. Risk of blood-transmitted diseases and an increasing number of blood substitutes
                           3.2.2.2. Emerging oral anticoagulants
                   3.3. Heparin Market Analysis Tools
                       3.3.1. Industry Analysis - Porter’s
                           3.3.1.1. Supplier power
                           3.3.1.2. Buyer power
                           3.3.1.3. Substitution threat
                           3.3.1.4. Threat of new entrant
                           3.3.1.5. Competitive rivalry
                       3.3.2. PESTEL Analysis
                           3.3.2.1. Political landscape
                           3.3.2.2. Technological landscape
                           3.3.2.3. Economic landscape
Chapter 4. Heparin Market: Type Estimates & Trend Analysis
                   4.1. Type Market Share, 2023 & 2030
                   4.2. Segment Dashboard
                   4.3. Global Heparin Market by Type Outlook
                   4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                       4.4.1. Low Molecular Weight Heparin
                           4.4.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                       4.4.2. Ultra-low Molecular Weight Heparin
                           4.4.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                       4.4.3. Unfractionated Heparin
                           4.4.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 5. Heparin Market: Route of Administration Estimates & Trend Analysis
                   5.1. Route of Administration Market Share, 2023 & 2030
                   5.2. Segment Dashboard
                   5.3. Global Heparin Market by Route of Administration Outlook
                   5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                       5.4.1. Intravenous
                           5.4.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                       5.4.2. Subcutaneous
                           5.4.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 6. Heparin Market: Application Estimates & Trend Analysis
                   6.1. Application Market Share, 2023 & 2030
                   6.2. Segment Dashboard
                   6.3. Global Heparin Market by Application Outlook
                   6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                       6.4.1. Venous Thromboembolism
                           6.4.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                       6.4.2. Atrial Fibrillation
                           6.4.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                       6.4.3. Renal Impairment
                           6.4.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                       6.4.4. Coronary Artery Disease
                           6.4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                       6.4.5. Others
                           6.4.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 7. Heparin Market: End-use Estimates & Trend Analysis
                   7.1. End-use Market Share, 2023 & 2030
                   7.2. Segment Dashboard
                   7.3. Global Heparin Market by End-use Outlook
                   7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                       7.4.1. Outpatient
                           7.4.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                       7.4.2. Inpatient
                           7.4.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 8. Heparin Market: Source Estimates & Trend Analysis
                   8.1. Source Market Share, 2023 & 2030
                   8.2. Segment Dashboard
                   8.3. Global Heparin Market by Source Outlook
                   8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                       8.4.1. Porcine
                           8.4.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                       8.4.2. Bovine
                           8.4.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
                       8.4.3. Others
                           8.4.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 9. Heparin Market: Regional Estimates & Trend Analysis
                   9.1. Regional Market Share Analysis, 2023 & 2030
                   9.2. Regional Market Dashboard
                   9.3. Global Regional Market Snapshot
                   9.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030
                   9.5. North America
                       9.5.1. U.S.
                           9.5.1.1. Key country dynamics
                           9.5.1.2. Regulatory framework/ reimbursement structure
                           9.5.1.3. Competitive scenario
                           9.5.1.4. U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
                       9.5.2. Canada
                           9.5.2.1. Key country dynamics
                           9.5.2.2. Regulatory framework/ reimbursement structure
                           9.5.2.3. Competitive scenario
                           9.5.2.4. Canada market estimates and forecasts, 2018 - 2030 (USD Million)
                   9.6. Europe
                       9.6.1. UK
                           9.6.1.1. Key country dynamics
                           9.6.1.2. Regulatory framework/ reimbursement structure
                           9.6.1.3. Competitive scenario
                           9.6.1.4. UK market estimates and forecasts, 2018 - 2030 (USD Million)
                       9.6.2. Germany
                           9.6.2.1. Key country dynamics
                           9.6.2.2. Regulatory framework/ reimbursement structure
                           9.6.2.3. Competitive scenario
                           9.6.2.4. Germany market estimates and forecasts, 2018 - 2030 (USD Million)
                       9.6.3. France
                           9.6.3.1. Key country dynamics
                           9.6.3.2. Regulatory framework/ reimbursement structure
                           9.6.3.3. Competitive scenario
                           9.6.3.4. France market estimates and forecasts, 2018 - 2030 (USD Million)
                       9.6.4. Italy
                           9.6.4.1. Key country dynamics
                           9.6.4.2. Regulatory framework/ reimbursement structure
                           9.6.4.3. Competitive scenario
                           9.6.4.4. Italy market estimates and forecasts, 2018 - 2030 (USD Million)
                       9.6.5. Spain
                           9.6.5.1. Key country dynamics
                           9.6.5.2. Regulatory framework/ reimbursement structure
                           9.6.5.3. Competitive scenario
                           9.6.5.4. Spain market estimates and forecasts, 2018 - 2030 (USD Million)
                       9.6.6. Norway
                           9.6.6.1. Key country dynamics
                           9.6.6.2. Regulatory framework/ reimbursement structure
                           9.6.6.3. Competitive scenario
                           9.6.6.4. Norway market estimates and forecasts, 2018 - 2030 (USD Million)
                       9.6.7. Sweden
                           9.6.7.1. Key country dynamics
                           9.6.7.2. Regulatory framework/ reimbursement structure
                           9.6.7.3. Competitive scenario
                           9.6.7.4. Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
                       9.6.8. Denmark
                           9.6.8.1. Key country dynamics
                           9.6.8.2. Regulatory framework/ reimbursement structure
                           9.6.8.3. Competitive scenario
                           9.6.8.4. Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
                   9.7. Asia Pacific
                       9.7.1. Japan
                           9.7.1.1. Key country dynamics
                           9.7.1.2. Regulatory framework/ reimbursement structure
                           9.7.1.3. Competitive scenario
                           9.7.1.4. Japan market estimates and forecasts, 2018 - 2030 (USD Million)
                       9.7.2. China
                           9.7.2.1. Key country dynamics
                           9.7.2.2. Regulatory framework/ reimbursement structure
                           9.7.2.3. Competitive scenario
                           9.7.2.4. China market estimates and forecasts, 2018 - 2030 (USD Million)
                       9.7.3. India
                           9.7.3.1. Key country dynamics
                           9.7.3.2. Regulatory framework/ reimbursement structure
                           9.7.3.3. Competitive scenario
                           9.7.3.4. India market estimates and forecasts, 2018 - 2030 (USD Million)
                       9.7.4. Australia
                           9.7.4.1. Key country dynamics
                           9.7.4.2. Regulatory framework/ reimbursement structure
                           9.7.4.3. Competitive scenario
                           9.7.4.4. Australia market estimates and forecasts, 2018 - 2030 (USD Million)
                       9.7.5. South Korea
                           9.7.5.1. Key country dynamics
                           9.7.5.2. Regulatory framework/ reimbursement structure
                           9.7.5.3. Competitive scenario
                           9.7.5.4. South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
                       9.7.6. Thailand
                           9.7.6.1. Key country dynamics
                           9.7.6.2. Regulatory framework/ reimbursement structure
                           9.7.6.3. Competitive scenario
                           9.7.6.4. Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
                   9.8. Latin America
                       9.8.1. Brazil
                           9.8.1.1. Key country dynamics
                           9.8.1.2. Regulatory framework/ reimbursement structure
                           9.8.1.3. Competitive scenario
                           9.8.1.4. Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
                       9.8.2. Mexico
                           9.8.2.1. Key country dynamics
                           9.8.2.2. Regulatory framework/ reimbursement structure
                           9.8.2.3. Competitive scenario
                           9.8.2.4. Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
                       9.8.3. Argentina
                           9.8.3.1. Key country dynamics
                           9.8.3.2. Regulatory framework/ reimbursement structure
                           9.8.3.3. Competitive scenario
                           9.8.3.4. Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
                   9.9. MEA
                       9.9.1. South Africa
                           9.9.1.1. Key country dynamics
                           9.9.1.2. Regulatory framework/ reimbursement structure
                           9.9.1.3. Competitive scenario
                           9.9.1.4. South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
                       9.9.2. Saudi Arabia
                           9.9.2.1. Key country dynamics
                           9.9.2.2. Regulatory framework/ reimbursement structure
                           9.9.2.3. Competitive scenario
                           9.9.2.4. Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
                       9.9.3. UAE
                           9.9.3.1. Key country dynamics
                           9.9.3.2. Regulatory framework/ reimbursement structure
                           9.9.3.3. Competitive scenario
                           9.9.3.4. UAE market estimates and forecasts, 2018 - 2030 (USD Million)
                       9.9.4. Kuwait
                           9.9.4.1. Key country dynamics
                           9.9.4.2. Regulatory framework/ reimbursement structure
                           9.9.4.3. Competitive scenario
                           9.9.4.4. Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 10. Competitive Landscape
                   10.1. Recent Developments & Impact Analysis, By Key Market Participants
                   10.2. Company/Competition Categorization
                   10.3. Vendor Landscape
                       10.3.1. List of key distributors and channel partners
                       10.3.2. Key customers
                       10.3.3. Key company market share analysis, 2023
                       10.3.4. Pfizer Inc.
                           10.3.4.1. Company overview
                           10.3.4.2. Financial performance
                           10.3.4.3. Type benchmarking
                           10.3.4.4. Strategic initiatives
                       10.3.5. LEO Pharma A/S
                           10.3.5.1. Company overview
                           10.3.5.2. Financial performance
                           10.3.5.3. Type benchmarking
                           10.3.5.4. Strategic initiatives
                       10.3.6. Dr. Reddy’s Laboratories Ltd.
                           10.3.6.1. Company overview
                           10.3.6.2. Financial performance
                           10.3.6.3. Type benchmarking
                           10.3.6.4. Strategic initiatives
                       10.3.7. GlaxoSmithKline plc
                           10.3.7.1. Company overview
                           10.3.7.2. Financial performance
                           10.3.7.3. Type benchmarking
                           10.3.7.4. Strategic initiatives
                       10.3.8. Sanofi
                           10.3.8.1. Company overview
                           10.3.8.2. Financial performance
                           10.3.8.3. Type benchmarking
                           10.3.8.4. Strategic initiatives
                       10.3.9. Aspen Holdings
                           10.3.9.1. Company overview
                           10.3.9.2. Financial performance
                           10.3.9.3. Type benchmarking
                           10.3.9.4. Strategic initiatives
                       10.3.10. Fresenius SE & Co. KGaA
                           10.3.10.1. Company overview
                           10.3.10.2. Financial performance
                           10.3.10.3. Type benchmarking
                           10.3.10.4. Strategic initiatives
                       10.3.11. B. Braun Medical, Inc.
                           10.3.11.1. Company overview
                           10.3.11.2. Financial performance
                           10.3.11.3. Type benchmarking
                           10.3.11.4. Strategic initiatives
                       10.3.12. Sandoz (Novartis AG)
                           10.3.12.1. Company overview
                           10.3.12.2. Financial performance
                           10.3.12.3. Type benchmarking
                           10.3.12.4. Strategic initiatives

List of Tables

Table 1 List of abbreviations
Table 2 North America Heparin market, by region, 2018 - 2030 (USD Million)
Table 3 North America Heparin market, by type, 2018 - 2030 (USD Million)
Table 4 North America Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 5 North America Heparin market, by application, 2018 - 2030 (USD Million)
Table 6 North America Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 7 North America Heparin market, by source, 2018 - 2030 (USD Million)
Table 8 U.S. Heparin market, by type, 2018 - 2030 (USD Million)
Table 9 U.S. Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 10 U.S. Heparin market, by application, 2018 - 2030 (USD Million)
Table 11 U.S. Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 12 U.S. Heparin market, by source, 2018 - 2030 (USD Million)
Table 13 Canada Heparin market, by type, 2018 - 2030 (USD Million)
Table 14 Canada Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 15 Canada Heparin market, by application, 2018 - 2030 (USD Million)
Table 16 Canada Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 17 Canada Heparin market, by source, 2018 - 2030 (USD Million)
Table 18 Europe Heparin market, by region, 2018 - 2030 (USD Million)
Table 19 Europe Heparin market, by type, 2018 - 2030 (USD Million)
Table 20 Europe Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 21 Europe Heparin market, by application, 2018 - 2030 (USD Million)
Table 22 Europe Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 23 Europe Heparin market, by source, 2018 - 2030 (USD Million)
Table 24 Germany Heparin market, by type, 2018 - 2030 (USD Million)
Table 25 Germany Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 26 Germany Heparin market, by application, 2018 - 2030 (USD Million)
Table 27 Germany Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 28 Germany Heparin market, by source, 2018 - 2030 (USD Million)
Table 29 UK Heparin market, by type, 2018 - 2030 (USD Million)
Table 30 UK Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 31 UK Heparin market, by application, 2018 - 2030 (USD Million)
Table 32 UK Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 33 UK Heparin market, by source, 2018 - 2030 (USD Million)
Table 34 France Heparin market, by type, 2018 - 2030 (USD Million)
Table 35 France Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 36 France Heparin market, by application, 2018 - 2030 (USD Million)
Table 37 France Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 38 France Heparin market, by source, 2018 - 2030 (USD Million)
Table 39 Italy Heparin market, by type, 2018 - 2030 (USD Million)
Table 40 Italy Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 41 Italy Heparin market, by application, 2018 - 2030 (USD Million)
Table 42 Italy Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 43 Italy Heparin market, by source, 2018 - 2030 (USD Million)
Table 44 Spain Heparin market, by type, 2018 - 2030 (USD Million)
Table 45 Spain Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 46 Spain Heparin market, by application, 2018 - 2030 (USD Million)
Table 47 Spain Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 48 Spain Heparin market, by source, 2018 - 2030 (USD Million)
Table 49 Denmark Heparin market, by type, 2018 - 2030 (USD Million)
Table 50 Denmark Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 51 Denmark Heparin market, by application, 2018 - 2030 (USD Million)
Table 52 Denmark Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 53 Denmark Heparin market, by source, 2018 - 2030 (USD Million)
Table 54 Sweden Heparin market, by type, 2018 - 2030 (USD Million)
Table 55 Sweden Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 56 Sweden Heparin market, by application, 2018 - 2030 (USD Million)
Table 57 Sweden Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 58 Sweden Heparin market, by source, 2018 - 2030 (USD Million)
Table 59 Norway Heparin market, by type, 2018 - 2030 (USD Million)
Table 60 Norway Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 61 Norway Heparin market, by application, 2018 - 2030 (USD Million)
Table 62 Norway Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 63 Norway Heparin market, by source, 2018 - 2030 (USD Million)
Table 64 Asia Pacific Heparin market, by region, 2018 - 2030 (USD Million)
Table 65 Asia Pacific Heparin market, by type, 2018 - 2030 (USD Million)
Table 66 Asia Pacific Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 67 Asia Pacific Heparin market, by application, 2018 - 2030 (USD Million)
Table 68 Asia Pacific Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 69 Asia Pacific Heparin market, by source, 2018 - 2030 (USD Million)
Table 70 China Heparin market, by type, 2018 - 2030 (USD Million)
Table 71 China Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 72 China Heparin market, by application, 2018 - 2030 (USD Million)
Table 73 China Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 74 China Heparin market, by source, 2018 - 2030 (USD Million)
Table 75 Japan Heparin market, by type, 2018 - 2030 (USD Million)
Table 76 Japan Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 77 Japan Heparin market, by application, 2018 - 2030 (USD Million)
Table 78 Japan Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 79 Japan Heparin market, by source, 2018 - 2030 (USD Million)
Table 80 India Heparin market, by type, 2018 - 2030 (USD Million)
Table 81 India Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 82 India Heparin market, by application, 2018 - 2030 (USD Million)
Table 83 India Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 84 India Heparin market, by source, 2018 - 2030 (USD Million)
Table 85 South Korea Heparin market, by type, 2018 - 2030 (USD Million)
Table 86 South Korea Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 87 South Korea Heparin market, by application, 2018 - 2030 (USD Million)
Table 88 South Korea Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 89 South Korea Heparin market, by source, 2018 - 2030 (USD Million)
Table 90 Australia Heparin market, by type, 2018 - 2030 (USD Million)
Table 91 Australia Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 92 Australia Heparin market, by application, 2018 - 2030 (USD Million)
Table 93 Australia Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 94 Australia Heparin market, by source, 2018 - 2030 (USD Million)
Table 95 Thailand Heparin market, by type, 2018 - 2030 (USD Million)
Table 96 Thailand Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 97 Thailand Heparin market, by application, 2018 - 2030 (USD Million)
Table 98 Thailand Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 99 Thailand Heparin market, by source, 2018 - 2030 (USD Million)
Table 100 Latin America Heparin market, by region, 2018 - 2030 (USD Million)
Table 101 Latin America Heparin market, by type, 2018 - 2030 (USD Million)
Table 102 Latin America Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 103 Latin America Heparin market, by application, 2018 - 2030 (USD Million)
Table 104 Latin America Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 105 Latin America Heparin market, by source, 2018 - 2030 (USD Million)
Table 106 Brazil Heparin market, by type, 2018 - 2030 (USD Million)
Table 107 Brazil Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 108 Brazil Heparin market, by application, 2018 - 2030 (USD Million)
Table 109 Brazil Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 110 Brazil Heparin market, by source, 2018 - 2030 (USD Million)
Table 111 Mexico Heparin market, by type, 2018 - 2030 (USD Million)
Table 112 Mexico Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 113 Mexico Heparin market, by application, 2018 - 2030 (USD Million)
Table 114 Mexico Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 115 Mexico Heparin market, by source, 2018 - 2030 (USD Million)
Table 116 Argentina Heparin market, by type, 2018 - 2030 (USD Million)
Table 117 Argentina Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 118 Argentina Heparin market, by application, 2018 - 2030 (USD Million)
Table 119 Argentina Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 120 Argentina Heparin market, by source, 2018 - 2030 (USD Million)
Table 121 MEA Heparin market, by region, 2018 - 2030 (USD Million)
Table 122 MEA Heparin market, by type, 2018 - 2030 (USD Million)
Table 123 MEA Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 124 MEA Heparin market, by application, 2018 - 2030 (USD Million)
Table 125 MEA Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 126 MEA Heparin market, by source, 2018 - 2030 (USD Million)
Table 127 South Africa Heparin market, by type, 2018 - 2030 (USD Million)
Table 128 South Africa Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 129 South Africa Heparin market, by application, 2018 - 2030 (USD Million)
Table 130 South Africa Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 131 South Africa Heparin market, by source, 2018 - 2030 (USD Million)
Table 132 Saudi Arabia Heparin market, by type, 2018 - 2030 (USD Million)
Table 133 Saudi Arabia Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 134 Saudi Arabia Heparin market, by application, 2018 - 2030 (USD Million)
Table 135 Saudi Arabia Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 136 Saudi Arabia Heparin market, by source, 2018 - 2030 (USD Million)
Table 137 UAE Heparin market, by type, 2018 - 2030 (USD Million)
Table 138 UAE Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 139 UAE Heparin market, by application, 2018 - 2030 (USD Million)
Table 140 UAE Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 141 UAE Heparin market, by source, 2018 - 2030 (USD Million)
Table 142 Kuwait Heparin market, by type, 2018 - 2030 (USD Million)
Table 143 Kuwait Heparin market, by route of administration, 2018 - 2030 (USD Million)
Table 144 Kuwait Heparin market, by application, 2018 - 2030 (USD Million)
Table 145 Kuwait Heparin market, by end-use, 2018 - 2030 (USD Million)
Table 146 Kuwait Heparin market, by source, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Heparin market: market outlook
Fig. 14 Heparin competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Heparin market driver impact
Fig. 20 Heparin market restraint impact
Fig. 21 Heparin market strategic initiatives analysis
Fig. 22 Heparin market: Type movement analysis
Fig. 23 Heparin market: Type outlook and key takeaways
Fig. 24 Low molecular weight heparin market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Ultra-low molecular weight heparin market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Unfractionated Heparin market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Heparin market: Route of Administration movement Analysis
Fig. 28 Heparin market: Route of Administration outlook and key takeaways
Fig. 29 Intravenous market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Subcutaneous market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Heparin market: Application movement analysis
Fig. 32 Heparin market: Application outlook and key takeaways
Fig. 33 Venous thromboembolism market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Atrial fibrillation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Renal impairment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Coronary artery disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Heparin market: End-use movement analysis
Fig. 39 Heparin market: End-use outlook and key takeaways
Fig. 40 Outpatient market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Inpatient market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Heparin market: Source movement analysis
Fig. 43 Heparin market: Source outlook and key takeaways
Fig. 44 Porcine market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Bovine market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Global Heparin market: Regional movement analysis
Fig. 48 Global Heparin market: Regional outlook and key takeaways
Fig. 49 Global Heparin market share and leading players
Fig. 50 North America market share and leading players
Fig. 51 Europe market share and leading players
Fig. 52 Asia Pacific market share and leading players
Fig. 53 Latin America market share and leading players
Fig. 54 Middle East & Africa market share and leading players
Fig. 55 North America: SWOT
Fig. 56 Europe SWOT
Fig. 57 Asia Pacific SWOT
Fig. 58 Latin America SWOT
Fig. 59 MEA SWOT
Fig. 60 North America, by country
Fig. 61 North America
Fig. 62 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 U.S.
Fig. 64 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Canada
Fig. 66 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Europe
Fig. 68 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 UK
Fig. 70 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Germany
Fig. 72 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 France
Fig. 74 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 75 Italy
Fig. 76 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 77 Spain
Fig. 78 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 Denmark
Fig. 80 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 Sweden
Fig. 82 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 83 Norway
Fig. 84 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 85 Asia Pacific
Fig. 86 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 87 China
Fig. 88 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 89 Japan
Fig. 90 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 91 India
Fig. 92 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 93 Thailand
Fig. 94 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 95 South Korea
Fig. 96 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 97 Australia
Fig. 98 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 99 Latin America
Fig. 100 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 101 Brazil
Fig. 102 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 103 Mexico
Fig. 104 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 105 Argentina
Fig. 106 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 107 Middle East and Africa
Fig. 108 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 109 South Africa
Fig. 110 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 111 Saudi Arabia
Fig. 112 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 113 UAE
Fig. 114 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 115 Kuwait
Fig. 116 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 117 Market share of key market players- Heparin market